Immunohistochemical detection of β-catenin and adenomatous polyposis coli in ameloblastomas

Journal of Oral Pathology and Medicine

Volumn 34, Issue 7, 2005, Pages 401-406

  Kumamoto, Hiroyuki ^a   Ooya, K ^a  

^a TOHOKU UNIVERSITY   (Japan)

Author keywords

catenin; Adenomatous polyposis coli; Ameloblastoma; Wnt pathway

Indexed keywords

APC PROTEIN; BETA CATENIN; WNT PROTEIN;

AMELOBLASTOMA; ARTICLE; BASEMENT MEMBRANE; CELL DIFFERENTIATION; CELL MEMBRANE; CELL NUCLEUS; COLON CARCINOGENESIS; CONTROLLED STUDY; CYTOPLASM; EPITHELIUM CELL; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MOLAR TOOTH; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TOOTH FLORA;

ADENOMATOUS POLYPOSIS COLI PROTEIN; AMELOBLASTOMA; ANIMALS; BETA CATENIN; CYTOSKELETAL PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; JAW NEOPLASMS; MICE; STATISTICS, NONPARAMETRIC; TOOTH GERM; TRANS-ACTIVATORS;

EID: 22344440776     PISSN: 09042512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2005.00328.x     Document Type: Article

References (40)

1. Kramer IRH, Pindborg JJ, Shear M. WHO histological typing of odontogenic tumours. Berlin: Springer-Verlag, 1992: 11-27.
2. Melrose RJ. Benign epithelial odontogenic tumors. Semin Diagn Pathol 1999; 16: 271-87.
3. Eversole LR. Malignant epithelial odontogenic tumors. Semin Diagn Pathol 1999; 16: 317-24.
4. Sciubba JJ, Fantasia JE, Kahn LB. Tumors and cysts of the jaw. Washington, DC: Armed Forces institute of Pathology, 2001: 71-99.
5. Heikinheimo K, Jee KJ, Niini T, et al. Gene expression profiling of ameloblastoma and human tooth germ by means of a cDNA microarray. J Dent Res 2002; 81: 525-30.
6. Jaakelainen K, Jee KJ, Leivo I, Saloniemi I, Knuutila S, Heikinheimo K. Cell proliferation and chromosomal changes in human ameloblastoma. Cancer Genet Cytogenet 2002; 136: 31-7.
7. Dale TC. Signal transduction by the Wnt family of ligands. Biochem J 1998; 329: 209-23.
8. Wodarz A, Nusse R. Mechanisms of Wnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88.
9. Polakis P. Wnt signaling and cancer. Genes Dev 2000; 14: 1837-51.
10. Munemitsu S, Albert I, Souza B, Rubinfeld B, Polakis P. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein. Proc Natl Acad Sci U S A 1995; 92: 3046-50.
11. Rubinfeld B, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P. Binding of GSK3β to the APC-β-catenin complex and regulation of complex assembly. Science 1996; 272: 1023-6.
12. Orford K, Crockett C, Jensen JP, Weissman AM, Byers SW. Serine phosphorylation-regulated ubiquitination and degradation of β-catenin. J Biol Chem 1997; 272: 24735-8.
13. Behrens J, von Kries JP, Kuhl M, et al. Functional interaction of β-catenin with the transcription factor LEF-1. Nature 1996; 382: 638-42.
14. He TC, Sparks AB, Rago C, et al. Identification of c-MYC as a target of the APC pathway. Science 1998; 281: 1509-12.
15. Tetsu O, McCormick F. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 1999; 398: 422-6.
16. Morin PJ, Sparks AB, Korinek V, et al. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC. Science 1997; 275: 1787-90.
17. Fearnhead NS, Britton MP, Bodmer WF. The ABC of APC. Hum Mol Genet 2001; 10: 721-33.
18. Kumamoto H, Ooya K. Expression of E-cadherin and α-catenin in epithelial odontogenic tumors: an immunohistochemical study. J Oral Pathol Med 1999; 28: 152-7.
19. Sekine S, Sato S, Takata T, et al. β-catenin mutations are frequent in calcifying odontogenic cysts, but rare in ameloblastomas. Am J Pathol 2003; 163: 1707-12.
20. Sarkar L, Sharpe PT. Expression of Wnt signalling pathway genes during tooth development. Mech Dev 1999; 85: 197-200.
21. Haegel H, Larue L, Ohsugi M, Fedorov L, Herrenknecht K, Kemler R. Lack of β-catenin affects mouse development at gastrulation. Development 1995; 121: 3529-37.
22. Moser AR, Shoemaker AR, Connelly CS, et al. Homozygosity for the Min allele of Ape results in disruption of mouse development prior to gastrulation. Dev Dyn 1995; 203: 422-33.
23. Wang M, Dobeck JM, Sorkin BC, Skobe Z. Adenomatous polyposis coli protein is expressed in alternate stages of the ameloblast life cycle. J Dent Res 1998; 77: 1979-82.
24. Fausser JL, Schlepp O, Aberdam D, Meneguzzi G, Ruch JV, Lesot H. Localization of antigens associated with adherens junctions, desmosomes, and hemidesmosomes during murine molar morphogenesis. Differentiation 1998; 63: 1-11.
25. Sorkin BC, Wang MY, Dobeck JM, Albergo KL, Skobe Z. The cadherin-catenin complex is expressed alternately with the adenomatous polyposis coli protein during rat incisor amelogenesis. J Histochem Cytochem 2000; 48: 397-406.
26. van Genderen C, Okamura RM, Farinas I, et al. Development of several organs that require inductive epithelial-mesenchymal interactions is impaired in LEF-1-deficient mice. Genes Dev 1994; 8: 2691-703.
27. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991; 66: 589-600.
28. Aggarwal VR, Sloan P, Horner K, et al. Dento-osseous changes as diagnostic markers in familial adenomatous polyposis families. Oral Dis 2003; 9: 29-33.
29. Ozawa M, Baribault H, Kemler R. The cytoplasmic domain of the cell adhesion molecule uvomorulin associates with three independent proteins structurally related in different species. EMBO J 1989; 8: 1711-7.
30. Chan EF, Gat U, McNiff JM, Fuchs E. A common human skin tumour is caused by activating mutations in β-catenin. Nat Genet 1999; 21: 410-3.
31. Kobayashi M, Honma T, Matsuda Y, et al. Nuclear translocation of beta-catenin in colorectal cancer. Br J Cancer 2000; 82: 1689-93.
32. Kato K, Nakatani Y, Kanno H, et al. Possible linkage between specific histological structures and aberrant reactivation of the Wnt pathway in adamantinomatous craniopharyngioma. J Pathol 2004; 203: 814-21.
33. Kumamoto H, Kimi K, Ooya K. Detection of cell cycle-related factors in ameloblastomas. J Oral Pathol Med 2001; 30: 309-15.
34. Kumamoto H, Kinouchi Y, Ooya K. Telomerase activity and telomerase reverse transciptase (TERT) expression in ameloblastomas. J Oral Pathol Med 2001; 30: 231-6.
35. Baeg GH, Matsumine A, Kuroda T, et al. The tumour suppressor gene product APC blocks cell cycle progression from G0/G1 to S phase. EMBO J 1995; 14: 5618-25.
36. Powell SM, Zilz N, Beazer-Barclay Y, et al. APC mutations occur early during colorectal tumorigenesis. Nature 1992; 359: 235-7.
37. Su LK, Kinzler KW, Vogelstein B, et al. Multiple intestinal neoplasia caused by a mutation in the murine homolog of the APC gene. Science 1992; 256: 668-70.
38. Miyashiro I, Senda T, Matsumine A, et al. Subcellular localization of the APC protein: immunoelectron microscopic study of the association of the APC protein with catenin. Oncogene 1995; 11: 89-96.
39. Kumamoto H. Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 1997; 26: 419-25.
40. Hulsken J, Birchmeier W, Behrens J. E-cadherin and APC compete for the interaction with β-catenin and the cytoskeleton. J Cell Biol 1994; 127: 2061-9.